Comparison of energy estimates in chronic kidney disease using doubly-labelled water by Sridharan, S et al.
Research Archive
Citation for published version:
S. Sridharan, J. Wong, E. Vilar, and K. Farrington, ‘Comparison 
of energy estimates in chronic kidney disease using doubly-
labelled water’, Journal of Human Nutrition and Dietetics, 
Vol. 29 (1): 59-66, February 2016.
DOI: 
https://doi.org/10.1111/jhn.12326
Document Version:
This is the Accepted Manuscript version.
The version in the University of Hertfordshire Research Archive 
may differ from the final published version.  Users should 
always cite the published version.
Copyright and Reuse: 
© 2015 The British Dietetic Association Ltd.  Published by 
John Wiley & Sons, Inc. 
This article may be used for non-commercial purposes in 
accordance with Wiley Terms and Conditions for Self-
Archiving.
Enquiries
If you believe this document infringes copyright, please contact the 
Research & Scholarly Communications Team at rsc@herts.ac.uk
 1 
ABSTRACT 
 
Background: 
Total energy expenditure (TEE) is estimated in clinical practice as a combined 
measure of resting energy expenditure and physical activity level. Commonly 
available questionnaires to estimate physical activity level have not been validated in 
patients with kidney disease using the doubly labelled water method. 
 
Methods: 
This prospective, cross-sectional study was conducted on 40 patients with Chronic 
Kidney Disease stages 1-5 with the objective of validating two physical activity 
questionnaires – Recent Physical Activity Questionnaire (RPAQ) and Stanford 7-day 
recall questionnaire. TEE was measured using doubly labelled water technique. TEE 
was also estimated using predicted resting energy expenditure and estimated physical 
activity measures from the questionnaires. 
 
Results: 
Measured TEE correlated better with TEE estimated from RPAQ compared to that 
from Stanford questionnaire. In Bland-Altman analysis, TEE estimated from RPAQ 
had the least bias and narrower limits of agreement compared to the measured TEE. A 
MET value of 1.3 for the unaccounted time in RPAQ provided the best approximation 
of estimated TEE to the measured TEE. 
 
Conclusions: 
RPAQ is an acceptable questionnaire tool to assess physical activity level in patients 
with chronic kidney disease. 
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INTRODUCTION 
 
Individuals with chronic kidney disease (CKD) often have poor appetite, especially in 
advanced stages, which could potentially contribute to low energy intake and protein-
energy wasting (1-3). Assessing total energy requirements of individuals is vital for 
appropriate nutritional management of these patients. In routine clinical practice, total 
energy requirements are estimated by a combined measure of estimated basal 
metabolic rate (i.e. resting energy expenditure) and estimated physical activity level. 
There are predictive equations for estimation of resting energy expenditure (REE) 
such as Harris-Benedict, Mifflin-St Jeor, Schofield and Henry equations which are 
commonly used in clinical practice. Recently, a novel disease-specific predictive 
equation for REE has also been published for use specifically in patients with renal 
disease (4). 
 
The estimation of physical activity is usually carried out by means of self-report 
physical activity questionnaire although prospectively completed activity diaries are 
an alternate option. Most of the readily available questionnaires are derived from 
young healthy adults and as such, may not be applicable to specific groups of patients. 
CKD is predominantly a disease of the elderly and these activity questionnaires may 
not be valid in this patient population. A study examining the validity of ten physical 
activity questionnaires in elderly individuals in general population has found that only 
a few questionnaires were reliable for use in elderly (5). Moreover, the individual 
variability was high for all the questionnaires which limits their use in clinical 
practice. 
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None of the physical activity questionnaires used in studies involving patients with 
kidney disease have been validated against the doubly labelled water (DLW) method 
for estimation of Total Energy Expenditure (TEE). Some of the available 
questionnaires have been tested against energy expenditure obtained from 
accelerometers. However, this is not ideal as accelerometer measurements themselves 
may also have a degree of associated measurement error. This error in itself has not 
been quantified using the DLW method in patients with kidney disease. Whilst 
accelerometers serve as the next best tool to DLW, it is important to validate physical 
activity questionnaires against DLW in individuals with kidney disease. 
 
Recent Physical Activity Questionnaire (RPAQ) enquires about the performance of 
various activities and the time spent on each of the reported activity over the 
preceding 4 weeks. The questionnaire has been validated in healthy individuals 
against DLW for categorising physical activity levels and estimation of Physical 
Activity-related Energy Expenditure (PAEE) (6). Each reported activity is assigned a 
Metabolic Equivalent of Task (MET) value as per the compendium of physical 
activities (7). However, the appropriate MET value for the unaccounted time is not 
clear. Stanford 7-day recall questionnaire was developed for the Stanford Five City 
Project (8) and has been validated in general population (9, 10). It has also been 
shown to have significant correlation with accelerometer-measured physical activity 
in patients with CKD (11). This questionnaire enquires about time spent on moderate, 
hard and very hard intensity activities and also sleep, over the preceding seven days. 
Any time not accounted for is considered to be spent performing light activities. 
These two questionnaires were chosen as the physical activity data from them could 
be easily converted to an energy expenditure measure. 
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Our aim in this study was to examine the validity of two physical activity 
questionnaires – RPAQ and Stanford 7-day recall questionnaire – for estimation of 
TEE in subjects with kidney disease. We also aimed to identify appropriate Metabolic 
Equivalent of Task (MET) value for unaccounted time in RPAQ that, when applied, 
will better reflect the measured TEE. 
 
SUBJECTS AND METHODS 
 
Ethical Review 
The study was approved by the National Research Ethics service. All subjects gave 
written informed consent to take part. 
 
Subjects 
Patients older than 18 years with CKD stages 1-5 and not on renal replacement 
therapy were recruited. Categorisation of patients with CKD stages 1 and 2 were 
based both on estimated glomerular filtration rate (eGFR) and presence of renal 
disease. Exclusion criteria were patients with untreated thyroid disease, active 
malignancy, ongoing infection, active vasculitis or connective tissue disease, history 
of hospitalisation in the last month, current pregnancy, cardiac pacemakers or 
defibrillators, unexplained weight loss, limb amputations and those who are known to 
have had positive serology for Hepatitis B, C or HIV. 
 
Study Protocol 
Data collection 
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The following data were collected on all participants. 
1. Demographic and anthropometric data including height and weight 
2. Comorbidity data, which was used to calculate Charlson Comorbidity Index 
3. REE 
4. TEE 
5. Physical activity assessment 
Height was measured using a wall-mounted stadiometer and weight was measured 
using a standard calibrated scale. 
 
Measurement of REE 
REE was measured by indirect calorimetry using a Sensormedics VMax series 29n 
metabolic cart (SensorMedics Corp, Yorba Linda, California, USA) as previously 
described (4). This measurement was carried out at the beginning of the 14-day study 
period. REE was also estimated using a recently published validated predictive 
equation specific for patients with kidney disease. This equation was derived and 
validated in a cohort of patients with end-stage renal disease (4). The commonly used 
existing REE predictive equations – Harris-Benedict (12), Mifflin-St Jeor (13), 
Schofield (14) and Henry (15) equations – were also used to estimate TEE. 
 
Measurement of TEE using DLW 
Following a baseline urine sample collection, subjects were asked to drink a measured 
dose of DLW comprising 0.083 g/kg body mass of 2H and 0.1375 g/kg of 18O. A 
small sample (approximately 1ml) from this dose was removed prior to administering 
and this sample was used to precisely measure the enrichment of the dose delivered. 
Subjects were asked to collect daily urine samples in water-tight containers for the 
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next 14 days and precisely record sample collection time. Subjects stored the urine 
samples in a refrigerator. The dose sample, baseline pre-dose urine and post-dose 
urine samples from days 1, 8 and 14 were analysed for 2H and 18O isotope enrichment 
using mass spectrometry. Sample masses were measured using a calibrated Sartorius 
Cubis balance with 0.1mg readability. CO2 production rate was calculated using a 
previously published revised equation (16). TEE was calculated from 14-day average 
daily CO2 production rate (from DLW) and respiratory quotient (from indirect 
calorimetry) according to Weir equation. 
 
Physical activity assessment 
At the end of the 14-day study period, subjects completed two physical activity 
questionnaires – RPAQ and Stanford. RPAQ is a validated questionnaire which 
enquires about various activities performed at home, work and at leisure time and the 
time spent in each of those activities over the preceding 4 weeks (6). The 
questionnaire enquires about the time spent in watching television, use of computer, 
number of times of stairs climbing at home, type and intensity of employment and 
activity frequency of a list of specific recreational activities. We also instructed the 
subjects to add any activities they have performed in the preceding 4 weeks that were 
not listed. It also enquires about the usual mode of travel such as car, public transport, 
cycle etc. 
 
Stanford questionnaire enquires about time spent in different intensities of activities at 
home and work in the preceding 7 days. It also enquires about the average daily 
duration of sleep in the same period. The specific activity intensities enquired were 
moderate, hard and very hard activities. Subjects were given a list of common 
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activities and their respective intensity categories along with the questionnaire to aid 
its completion. 
 
Estimation of TEE from RPAQ 
The metabolic cost of activity was expressed as MET value as per the Compendium 
of Physical Activities (7). The total reported activity duration was calculated by 
adding all the activity durations. If the total duration of reported activity exceeded 18 
hours per day, then the total and individual activity duration was normalised to 18 
hours. Assumption was made on the sleep duration. For those with reported activity 
duration of more than 16 hours, the sleep duration was assumed to be the remainder of 
the unreported activity time (6-8 hours). If the reported activity time was less than 16 
hours per day, then sleep duration was assumed to be 8 hours. This meant that there 
was a portion of time unaccounted for by the questionnaire. We assigned different 
MET values from 1 to 1.3 (in 0.05 increments) for this unaccounted time to explore 
the most accurate value that will achieve the best approximation of TEE to that 
measured from DLW method. TEE was also estimated using the recommended MET 
value for this unaccounted time as per previous literature (6). The recommended MET 
value is 1.3 if the individual’s common mode of travel is by walking or cycling and a 
value of 1 if any other mode of transport is specified. 
 
The MET value for each reported activity was multiplied by the duration of that 
activity. Similarly, assigned MET value for the unreported time and sleep was 
multiplied by the respective duration for the day. A total MET value, expressed as 
MET-hours/day, was calculated. This was then divided by 24 (hours) to give a mean 
daily MET.  TEErpaq was calculated by multiplying the daily MET by REE. Two 
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separate estimates of TEE was calculated – one using the measured REE and the other 
with the REE estimated from the predictive equation.  
 
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝐷𝐷𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷 𝑀𝑀𝑀𝑀𝑀𝑀 =  𝑀𝑀𝑇𝑇𝑇𝑇𝑀𝑀𝐷𝐷 𝐷𝐷𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷 𝑀𝑀𝑀𝑀𝑀𝑀24  
 
𝑀𝑀𝑀𝑀𝑀𝑀𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 (𝑘𝑘𝑘𝑘𝑀𝑀𝐷𝐷 𝑑𝑑𝑀𝑀𝐷𝐷⁄ ) = 𝑅𝑅𝑀𝑀𝑀𝑀 (𝑘𝑘𝑘𝑘𝑀𝑀𝐷𝐷 𝑑𝑑𝑀𝑀𝐷𝐷⁄ )  ×  𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝐷𝐷𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷 𝑀𝑀𝑀𝑀𝑀𝑀 
 
Estimate of TEE from Stanford Questionnaire 
Stanford questionnaire collects data on time spent on sleep and on moderate, hard and 
very hard activities over the preceding 7 days. Any unreported time was assumed to 
be spent performing light activities. Average MET value was allocated for each 
intensity of activity – 1 for sleep, 1.5 for light, 4 for moderate, 6 for hard and 10 for 
very hard activities. Mean daily MET was calculated using the following formula. 
 
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝐷𝐷𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷 𝑀𝑀𝑀𝑀𝑀𝑀
=  (𝑆𝑆 ×  1) +  (𝐿𝐿 ×  1.5) +  (𝑀𝑀 ×  4) + (𝐻𝐻 ×  6) +  (𝑉𝑉𝐻𝐻 ×  10)24 (ℎ𝑇𝑇𝑜𝑜𝑜𝑜𝑜𝑜)  
 
where S, L, M, H and VH are the time spent in sleep, light, moderate, hard and very 
hard activities respectively. TEEStan was calculated similar to TEErpaq from the above 
equation.  
 
The values of TEErpaq and TEEStan quoted in the remainder of the paper refer to those 
estimated using the novel predictive equation except where otherwise stated.  
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Physical activity related energy expenditure (PAEE) was calculated from each of the 
questionnaires as (0.9 x TEE) – REE (estimated using the novel predictive equation). 
PAEE from DLW was calculated similarly except that the measured REE was used in 
the equation. 
 
Statistical Analysis 
Statistical analysis was carried out using SPSS® version 19 (SPSS Software, IBM 
Corporation, Armonk, NY, USA). Normally distributed data are presented as mean ± 
standard deviation and non-normally distributed data as median (inter-quartile range). 
The significance of differences between means was determined using Student’s t-test 
and of medians by Mann-Whitney U-test. Comparison between questionnaire-derived 
TEE and PAEE and that from DLW method was carried out using Bland-Altman 
analysis (17). A p-value of < 0.05 was considered significant. 
 
RESULTS 
A total of 40 patients were studied – 21 patients with CKD stages 1-3 and 19 patients 
with CKD stages 4 and 5. Their main demographic and biochemical characteristics 
are shown in Table 1. 22 subjects (55%) were males. The underlying aetiology for 
CKD in patients with CKD stages 1-3 were IgA nephropathy (3 patients), Adult 
polycystic kidney disease (2), membranous nephropathy (3), minimal change disease 
(3), ischaemic nephropathy (3), lupus nephritis (2), ANCA associated vasculitis (1) 
and unknown in 2 subjects. In those with CKD stages 4-5, the commonest aetiology 
were Diabetic nephropathy (3),  IgA nephropathy (2), adult polycystic kidney disease 
(2) and unknown in 4 subjects. Ten subjects had diabetes mellitus of which 6 were 
treated with Insulin, 2 with oral hypoglycaemics and 2 were diet-controlled. All 
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patients were clinically euvolaemic. None of the patients were receiving diuretic 
therapy. There were no significant differences between the CKD groups with regards 
to demographic and body size parameters and comorbidity. As would be expected, 
eGFR and haemoglobin levels were lower in advanced CKD group. There was no 
significant difference in TEE (2384 vs 2485 kcal/day, p = 0.535) or physical-activity 
related energy expenditure (618 vs 640 kcal/day, p = 0.832) between the CKD groups 
1-3 and 4-5. 
 
The reported activity durations from RPAQ and Stanford questionnaires are shown in 
Table 2. The median reported activity time from RPAQ was 9.2 hours with sedentary 
activity being the major component of this time. The median unaccounted time from 
RPAQ was 6.8 hours. The median daily MET from Stanford questionnaire was 1.51 
with light intensity activity being the principal component. Except for the light 
activity duration from Stanford questionnaire, which was higher in females, there 
were no other gender differences in any of the activity times in either of the 
questionnaires. 
 
Estimates of TEE from RPAQ (TEErpaq) were calculated using different MET values 
for the unreported time from the questionnaire. The difference in TEE measured by 
DLW method (TEEdlw) and TEErpaq was calculated for each of these TEE estimates. 
Figure 1 shows the mean difference (bias) between TEEdlw and TEErpaq for each 
assigned MET value using estimated REE from the predictive equation. The 
corresponding limits of agreement for the bias values for each of these estimates are 
shown in Table 3. It can be seen that MET value of 1.3 for the unaccounted time had 
the least bias (108 kcal/day) using the estimated REE or the measured REE (171 
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kcal/day). Bias with MET values over 1.3 were similar but limits of agreement were 
very wide and unacceptable for clinical use. The same MET value also had the 
narrowest range of limits of agreement indicating better approximation of TEE 
estimate to that measured from DLW method (Table 3).  
 
Using MET value of 1.3 for the unaccounted time in RPAQ, TEE estimates were 
calculated using different REE predictive equations. Five predictive equations – the 
novel kidney disease-specific equation, Harris-Benedict, Mifflin-St Jeor, Schofield 
and Henry equations – were used. The bias and limits of agreement associated with 
each of the TEE estimates and TEEdlw are shown in Table 4. The novel equation had 
the least bias (108 kcal/day) and Mifflin-St Jeor the highest (285 kcal/day). The limits 
of agreement were comparable between TEE estimates from different equations. TEE 
was also estimated using measured REE and the above MET value. The bias for TEE 
estimate with measured REE was 171 kcal/day (limits of agreement: 1105 kcal/day, -
764 kcal/day). The bias estimates were similar using the PAEE from the Stanford 
questionnaire (ranging from -182 [novel equation] to +18 kcal [Mifflin-St Jeor]), the 
limits of agreement associated with the use of all the equations were very large.  
 
The mean TEEdlw was 2481 (± 476) kcal/day, TEErpaq was 2324 (± 538) kcal/day and 
TEEStan was 2615 (± 687) kcal/day. TEEdlw had a moderately strong correlation with 
TEErpaq (R2=0.576) and weaker correlation with TEEStan (R2=0.235). Bland-Altman 
plots comparing TEEdlw with TEErpaq and TEEStan are shown in Figures 2 and 3. The 
bias was less with TEErpaq (108 kcal/day) compared to that with TEEStan (-183 
kcal/day). Similarly, the limits of agreement were also narrower with TEErpaq. 
 
 12 
The mean PAEE estimated from DLW was 628 kcal/day, from RPAQ was 473 
kcal/day and that from Stanford questionnaire was 734 kcal/day. There was 
significant correlation between PAEE from DLW and that from RPAQ with a 
Spearman correlation coefficient (rho) of 0.408 (p = 0.009). The correlation between 
PAEE from DLW and Stanford questionnaire was not statistically significant (rho = 
0.302, p = 0.06). 
 
DISCUSSION 
 
The primary aim of this study was to examine the validity of the two physical activity 
questionnaires as tools to estimate TEE in clinical practice. The study showed the 
RPAQ questionnaire performs better for estimating energy requirements compared to 
Stanford 7-day recall questionnaire and has a higher correlation to TEE measured 
using the gold-standard doubly labelled water method. A MET value of 1.3 for the 
unreported time in RPAQ provides the best approximation of TEE from the 
questionnaire to the measured TEE. 
 
Assessing physical activity in patients with kidney disease can be beneficial in many 
ways. Firstly, it can help to identify patients with poor physical function. Secondly, it 
can be used to monitor the level of physical activity with disease progression and aid 
early detection of declining physical functioning. Finally, it can also be used to 
monitor the response to any clinical and psychological interventions related to 
physical activity levels. 
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The DLW method does not offer a practical solution for measurement of TEE in 
clinical practice due to the time-consuming nature and its cost. Furthermore, the 
method cannot be easily used in patients being treated with dialysis due to alterations 
to body water turnover. Physical activity questionnaires are useful tools to assess 
activity levels on a routine basis. Questionnaires developed in younger people are 
inaccurate when used in elderly population (18, 19). Patients with kidney disease are 
likely to be older adults and to have higher comorbidity and hence, the activity 
questionnaires need to be validated in this patient group. 
 
Two questionnaires – RPAQ and Stanford 7-day recall questionnaire – were 
examined for their validity in patients with kidney disease in this study. TEE derived 
from RPAQ correlated well with that measured from DLW method. The strong 
correlation of RPAQ derived TEE with TEEdlw implies the questionnaire is an 
acceptable tool for use in patients with kidney disease. On the other hand, Stanford 
questionnaire had a weaker correlation with TEEdlw with the R2 being 0.24. This is 
comparable to other questionnaires that have been examined in patients with kidney 
disease (11). Johansen et al compared 4 activity questionnaires against accelerometer 
derived energy expenditure data and found wide variations in the validity of these 
questionnaires (11). Human Activity Profile was the best performing questionnaire in 
that study with a R2 of 0.53 for the Adjusted Activity Score from the questionnaire 
and the Stanford questionnaire had a R2 of 0.35. In a review by Neilson et al, it was 
shown that the TEE derived from various questionnaires across many studies had only 
moderate correlation with TEE measured from DLW method (20). This highlights the 
limited capability of questionnaires for TEE estimation. However, the correlation 
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between RPAQ-derived TEE and that from DLW is better than many of the other 
currently available questionnaires for energy expenditure estimation. 
 
The superior performance of RPAQ over Stanford questionnaire may be due to the 
design of the questionnaire itself. RPAQ categorises activities into those at home, 
work and in leisure time. Also, it enquires about specific activities that are commonly 
performed everyday. Such a questionnaire design possibly aids in better recall of 
activities. In contrast, Stanford questionnaire enquires about overall time spent in 
every activity intensity level. Subjects may find it difficult to categorise their 
activities into appropriate intensity levels resulting in poor reporting of activity level. 
It is worth noting that this study involves only those with CKD and Stanford 
questionnaire may be a reliable tool in other disease conditions. 
 
There is a considerable amount of unreported time from RPAQ (median 6.8 hours per 
day) which does not include the sleep time. Excluding this time from TEE calculation 
will grossly underestimate the energy expenditure. The questionnaire captures higher 
intensity activities well with specific activities listed in detail. However, activities that 
are routinely carried out at home and low intensity activities are not specifically 
enquired for in the questionnaire. This may lead to these activities not being reported 
by patients. It is reasonable to assume that individuals are performing some activity – 
likely sedentary or low intensity activities – in this unreported time and hence, 
assigning an average MET value above 1 for this unreported time seems prudent. It is 
essential to identify an appropriate MET value to assign for this period which will 
enable better approximation of estimated TEE to the directly measured TEE from 
DLW method. 
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A range of MET values (1 to 1.3) for the unreported time in RPAQ was explored. Our 
study shows that TEE estimated by assigning a MET value of 1.3 for the unreported 
time was the closest to the measured TEE compared to other MET values. Not only 
did the MET value of 1.3 showed the least bias but the limits of agreement with 
TEEdlw were also narrower when compared to other MET values. Intuitively, this 
would seem the appropriate MET for the unreported time. A MET value of 1.3 is 
generally considered the threshold between sedentary and light activities. Patients are 
more likely to under-report sedentary activities especially when not specifically 
enquired about it and hence, it is possible that patients with kidney disease are 
performing sedentary activities during this time. However, it is worth noting that this 
value may not be applicable to certain subset of CKD patients performing at the 
extremes of physical activity levels. 
 
The novel predictive equation for REE has been shown to be at least as accurate as the 
existing ones and was associated with less bias in predicting REE (4). In keeping with 
these findings, TEE estimates using this equation also performed better compared to 
the existing general equations. Moreover, TEE estimate derived using this equation 
was comparable to those derived using measured REE values. Our findings highlight 
the importance of using disease-specific predictive equation for TEE estimation. 
 
Validity of activity questionnaires should not be assessed solely on correlations alone 
(21, 17, 22).  We used the Bland-Altman technique to compare TEE estimated from 
questionnaires to a gold standard DLW method. A limitation of our comparison is that 
the questionnaire measures activity for a time period that differed somewhat from the 
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14-day DLW study. If the questionnaire measures activity for a different time point 
than that measured by DLW, this may result in unreliable results from the 
questionnaire data (20). To mitigate this, we administered questionnaires at the end of 
the 14-day study period to reflect recalled physical activity during the latter part of the 
DLW measurement. 
 
In addition to the assumptions of the DLW method (23), the main limitations of the 
study are related to the use of questionnaires. Recall bias may have been a 
confounding factor in the accuracy of the data. This has been negated to some extent 
by enquiring about specific activities in the preceding weeks which facilitates recall of 
the activities by the subjects. Moreover, the strength of relationship between 
questionnaire data and DLW method is also in line with previously published 
literature. Finally, the study is limited by its relatively small sample size but the costs 
associated with DLW method restrict the use of this technique in large-scale studies. 
 
In conclusion, this is the first study to have validated activity questionnaires against 
doubly labelled water method in patients with kidney disease. This study has shown 
that RPAQ is an acceptable tool for assessment of activity level and TEE in CKD 
patients in conjunction with the disease-specific REE predictive equation or 
measurement of REE. The Stanford questionnaire, though showing some relationship 
to the measured TEE, does not perform as well as RPAQ in estimating TEE in this 
patient group. A MET value of 1.3 has been shown to be the best estimate of the 
activity level for the unreported time in RPAQ and use of this value is recommended 
when using RPAQ for patients with kidney disease. 
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Figure 1: Mean difference (bias) between TEEdlw and TEErpaq using estimated 
REE and various MET values for the unreported time 
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Figure 2: Bland-Altman plot showing bias and limits of agreement between 
TEEdlw and TEErpaq 
 
Difference between TEE measured by DLW and RPAQ plotted against the mean of the two 
measurements. A negative sign indicates an overestimation and a positive sign indicates an 
underestimation by the questionnaire. 
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Figure 3: Bland-Altman plot showing bias and limits of agreement between 
TEEdlw and TEEStan 
 
Difference between TEE measured by DLW and Stanford questionnaire plotted against the 
mean of the two measurements. A negative sign indicates an overestimation and a positive 
sign indicates an underestimation by the questionnaire. 
 
 
